UniProt ID | IF5A2_HUMAN | |
---|---|---|
UniProt AC | Q9GZV4 | |
Protein Name | Eukaryotic translation initiation factor 5A-2 | |
Gene Name | EIF5A2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 153 | |
Subcellular Localization |
Cytoplasm. Nucleus. Endoplasmic reticulum membrane Peripheral membrane protein Cytoplasmic side. Nucleus, nuclear pore complex. Hypusine modification promotes the nuclear export and cytoplasmic localization and there was a dynamic shift in the loca |
|
Protein Description | mRNA-binding protein involved in translation elongation. Has an important function at the level of mRNA turnover, probably acting downstream of decapping. Involved in actin dynamics and cell cycle progression, mRNA decay and probably in a pathway involved in stress response and maintenance of cell wall integrity. Functions as a regulator of apoptosis. Mediates effects of polyamines on neuronal process extension and survival. May play an important role in brain development and function, and in skeletal muscle stem cell differentiation (By similarity).. | |
Protein Sequence | MADEIDFTTGDAGASSTYPMQCSALRKNGFVVLKGRPCKIVEMSTSKTGKHGHAKVHLVGIDIFTGKKYEDICPSTHNMDVPNIKRNDYQLICIQDGYLSLLTETGEVREDLKLPEGELGKEIEGKYNAGEDVQVSVMCAMSEEYAVAIKPCK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MADEIDFTT ------CCCCCEECC | 24.12 | 22814378 | |
8 | Phosphorylation | MADEIDFTTGDAGAS CCCCCEECCCCCCCC | 26.56 | 25072903 | |
9 | Phosphorylation | ADEIDFTTGDAGASS CCCCEECCCCCCCCC | 32.81 | 25072903 | |
15 | Phosphorylation | TTGDAGASSTYPMQC CCCCCCCCCCCCCCC | 23.46 | 25072903 | |
16 | Phosphorylation | TGDAGASSTYPMQCS CCCCCCCCCCCCCCH | 31.27 | 25072903 | |
17 | Phosphorylation | GDAGASSTYPMQCSA CCCCCCCCCCCCCHH | 29.20 | 25072903 | |
18 | Phosphorylation | DAGASSTYPMQCSAL CCCCCCCCCCCCHHE | 9.92 | 25072903 | |
23 | Phosphorylation | STYPMQCSALRKNGF CCCCCCCHHEECCCE | 17.28 | 25072903 | |
27 | Acetylation | MQCSALRKNGFVVLK CCCHHEECCCEEEEC | 63.37 | 42347641 | |
27 | Sumoylation | MQCSALRKNGFVVLK CCCHHEECCCEEEEC | 63.37 | - | |
27 | Sumoylation | MQCSALRKNGFVVLK CCCHHEECCCEEEEC | 63.37 | - | |
27 | Ubiquitination | MQCSALRKNGFVVLK CCCHHEECCCEEEEC | 63.37 | 22817900 | |
34 | Neddylation | KNGFVVLKGRPCKIV CCCEEEECCCEEEEE | 41.06 | 32015554 | |
34 | Sumoylation | KNGFVVLKGRPCKIV CCCEEEECCCEEEEE | 41.06 | - | |
34 | Ubiquitination | KNGFVVLKGRPCKIV CCCEEEECCCEEEEE | 41.06 | 21906983 | |
34 | Sumoylation | KNGFVVLKGRPCKIV CCCEEEECCCEEEEE | 41.06 | - | |
39 | Sumoylation | VLKGRPCKIVEMSTS EECCCEEEEEEEECC | 53.09 | - | |
39 | Acetylation | VLKGRPCKIVEMSTS EECCCEEEEEEEECC | 53.09 | 42347625 | |
39 | Sumoylation | VLKGRPCKIVEMSTS EECCCEEEEEEEECC | 53.09 | - | |
39 | Ubiquitination | VLKGRPCKIVEMSTS EECCCEEEEEEEECC | 53.09 | 21906983 | |
44 | Phosphorylation | PCKIVEMSTSKTGKH EEEEEEEECCCCCCC | 18.94 | 29255136 | |
45 | Phosphorylation | CKIVEMSTSKTGKHG EEEEEEECCCCCCCC | 32.69 | 29255136 | |
46 | Phosphorylation | KIVEMSTSKTGKHGH EEEEEECCCCCCCCC | 22.40 | 29255136 | |
47 | Acetylation | IVEMSTSKTGKHGHA EEEEECCCCCCCCCE | 62.48 | 37092633 | |
47 | Ubiquitination | IVEMSTSKTGKHGHA EEEEECCCCCCCCCE | 62.48 | 29967540 | |
50 | Other | MSTSKTGKHGHAKVH EECCCCCCCCCEEEE | 52.20 | 14622290 | |
50 | Ubiquitination | MSTSKTGKHGHAKVH EECCCCCCCCCEEEE | 52.20 | 22817900 | |
50 | Hypusine | MSTSKTGKHGHAKVH EECCCCCCCCCEEEE | 52.20 | - | |
55 | Ubiquitination | TGKHGHAKVHLVGID CCCCCCEEEEEEEEE | 25.23 | 22817900 | |
65 | Phosphorylation | LVGIDIFTGKKYEDI EEEEECCCCCCHHHC | 48.72 | 21712546 | |
67 | Sumoylation | GIDIFTGKKYEDICP EEECCCCCCHHHCCC | 49.47 | - | |
67 | Ubiquitination | GIDIFTGKKYEDICP EEECCCCCCHHHCCC | 49.47 | 23000965 | |
67 | Sumoylation | GIDIFTGKKYEDICP EEECCCCCCHHHCCC | 49.47 | - | |
67 | Acetylation | GIDIFTGKKYEDICP EEECCCCCCHHHCCC | 49.47 | 42347637 | |
67 | Neddylation | GIDIFTGKKYEDICP EEECCCCCCHHHCCC | 49.47 | 32015554 | |
68 | Ubiquitination | IDIFTGKKYEDICPS EECCCCCCHHHCCCC | 56.04 | 23000965 | |
68 | Sumoylation | IDIFTGKKYEDICPS EECCCCCCHHHCCCC | 56.04 | - | |
68 | Acetylation | IDIFTGKKYEDICPS EECCCCCCHHHCCCC | 56.04 | 42347645 | |
68 | Sumoylation | IDIFTGKKYEDICPS EECCCCCCHHHCCCC | 56.04 | - | |
68 | Methylation | IDIFTGKKYEDICPS EECCCCCCHHHCCCC | 56.04 | - | |
69 | Phosphorylation | DIFTGKKYEDICPST ECCCCCCHHHCCCCC | 23.48 | 28796482 | |
73 | S-nitrosylation | GKKYEDICPSTHNMD CCCHHHCCCCCCCCC | 3.17 | 22126794 | |
73 | S-nitrosocysteine | GKKYEDICPSTHNMD CCCHHHCCCCCCCCC | 3.17 | - | |
75 | Phosphorylation | KYEDICPSTHNMDVP CHHHCCCCCCCCCCC | 37.58 | 25849741 | |
76 | Phosphorylation | YEDICPSTHNMDVPN HHHCCCCCCCCCCCC | 11.47 | 25849741 | |
85 | Sumoylation | NMDVPNIKRNDYQLI CCCCCCCCCCCEEEE | 52.36 | - | |
85 | Ubiquitination | NMDVPNIKRNDYQLI CCCCCCCCCCCEEEE | 52.36 | 21906983 | |
85 | Sumoylation | NMDVPNIKRNDYQLI CCCCCCCCCCCEEEE | 52.36 | - | |
89 | Phosphorylation | PNIKRNDYQLICIQD CCCCCCCEEEEEEEC | 14.57 | 24719451 | |
113 | Ubiquitination | GEVREDLKLPEGELG CCCCCCCCCCCCCHH | 74.45 | 29967540 | |
121 | Ubiquitination | LPEGELGKEIEGKYN CCCCCHHCEEECCCC | 69.05 | 29967540 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of IF5A2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of IF5A2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of IF5A2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
RAB30_HUMAN | RAB30 | physical | 21988832 | |
PTBP2_HUMAN | PTBP2 | physical | 21988832 | |
NIF3L_HUMAN | NIF3L1 | physical | 25416956 | |
MYCBP_HUMAN | MYCBP | physical | 26344197 | |
TAGL2_HUMAN | TAGLN2 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-47, AND MASS SPECTROMETRY. | |
"Substrate and functional diversity of lysine acetylation revealed bya proteomics survey."; Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T.,Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.-J., Zhao Y.; Mol. Cell 23:607-618(2006). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-68, AND MASS SPECTROMETRY. |